Home NDC 63539-274 Velsipity
Product NDC 63539-274
11-digit product format 635390274
Labeler code 63539
Product ID 63539-274_e566a7bd-2d3f-40f6-afc8-b2b24f563530
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name etrasimod
Dosage form TABLET, FILM COATED
Route ORAL
Labeler U.S. Pharmaceuticals
Application NDA216956
Marketing category NDA
Marketing start 2023-11-09
Substance ETRASIMOD ARGININE
Active strength 2 mg/1
Pharmacologic classes Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N216956-001 VELSIPITY ETRASIMOD ARGININE EQ 2MG BASE TABLET / ORAL RLD, RS 2023-10-12
Orange Book patents# Current patent rows page 1 of 1 · 9 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N216956-001 9126932 2029-07-22 U-3732 2023-11-09 N216956-001 8580841 2030-03-05 Drug substance, Drug product 2023-11-09 N216956-001 11007175 2036-01-06 U-3730 2023-11-09 N216956-001 12156866 2036-01-06 U-4047 2024-12-20 N216956-001 12377071 2036-01-06 U-4255 2025-09-03 N216956-001 10301262 2036-06-21 Drug substance, Drug product 2023-11-09 N216956-001 10676435 2036-06-21 U-3731 2023-11-09 N216956-001 11091435 2036-06-21 Drug substance, Drug product 2023-11-09 N216956-001 11884626 2036-06-21 U-3731 2024-02-28
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N216956-001 NCE 2028-10-12
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-01 22:54:32 2026-06 N216956-001 VELSIPITY EQ 2MG BASE TABLET / ORAL RLD, RS 2023-10-12 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-01 22:54:32 2026-06 N216956-001 9126932 2029-07-22 U-3732 2023-11-09 a50c72e98297…2026-08-01 22:54:32 2026-06 N216956-001 8580841 2030-03-05 Drug substance, Drug product 2023-11-09 a50c72e98297…2026-08-01 22:54:32 2026-06 N216956-001 11007175 2036-01-06 U-3730 2023-11-09 a50c72e98297…2026-08-01 22:54:32 2026-06 N216956-001 12156866 2036-01-06 U-4047 2024-12-20 a50c72e98297…2026-08-01 22:54:32 2026-06 N216956-001 12377071 2036-01-06 U-4255 2025-09-03 a50c72e98297…2026-08-01 22:54:32 2026-06 N216956-001 10301262 2036-06-21 Drug substance, Drug product 2023-11-09 a50c72e98297…2026-08-01 22:54:32 2026-06 N216956-001 10676435 2036-06-21 U-3731 2023-11-09 a50c72e98297…2026-08-01 22:54:32 2026-06 N216956-001 11091435 2036-06-21 Drug substance, Drug product 2023-11-09 a50c72e98297…2026-08-01 22:54:32 2026-06 N216956-001 11884626 2036-06-21 U-3731 2024-02-28 a50c72e98297…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-08-01 22:54:32 2026-06 N216956-001 NCE 2028-10-12 a50c72e98297…
openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Velsipity ETRASIMOD Pfizer Laboratories Div Pfizer Inc 65171e4a-d136-4abc-b08c-c40c1b486ff6 2025-08-18 Warnings, Adverse reactions Exact identifier application applno (NDA): 216956 application number: NDA216956
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 63539-274-28 Velsipity 28 in 1 BLISTER PACK TABLET, FILM COATED 28 4 63539-274-30 Velsipity 1 in 1 CARTON TABLET, FILM COATED 1 4 63539-274-30 Velsipity 30 in 1 BOTTLE TABLET, FILM COATED 30 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 63539-274 VELSIPITY (ETRASIMOD) TABLET, FILM COATED [U.S. PHARMACEUTICALS] 2 Current NDC, 3 package rows 20240927_d5b2a717-1b5c-4aed-a69c-64a0c4561c40.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 63539-274-28 63539027428 28 TABLET, FILM COATED in 1 BLISTER PACK (63539-274-28) 2023-11-09 Yes No Historical 63539-274-30 63539027430 1 BOTTLE in 1 CARTON (63539-274-30) / 30 TABLET, FILM COATED in 1 BOTTLE 1 bottle 2023-11-09 Yes No Historical